Skip to main content

Advertisement

SpringerLink
Log in

DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

Hodgkin lymphoma (HL) is characterized by the presence of Hodgkin and Reed-Sternberg cells. Epstein-Barr virus (EBV) infection is thought to play an important role in the development of HL. Although epigenetic alterations, such as aberrant DNA methylation, are known to contribute to the pathogenesis of various malignancies, little is known about such alterations in HL and their putative relationships with EBV infection.

Methods

We investigated promoter methylation patterns of seven tumor-associated genes in 53 primary HL cases using methylation-specific PCR (MS-PCR). Concomitantly, the EBV infection status was assessed using PCR, in situ hybridization and immunohistochemistry.

Results

The gene promoter hypermethylation frequencies observed were 77.3 % for P16, 58.5 % for RASSF1A, 50.9 % for CDH1, 45.3 % for DAPK, 43.4 % for GSTP1, 37.7 % for SHP1 and 24.3 % for MGMT. SHP1 gene promoter hypermethylation was more frequently observed in patients at extreme ages (i.e., ≤ 15 and >54 years) than in adult patients (p = 0.006) and in patients with B symptoms (p = 0.03). Interestingly, most of the analyzed gene promoters were more frequently hypermethylated in EBV-negative than in EBV-positive cases, in particular the DAPK gene promoter (58 % versus 27 %, p = 0.04). Furthermore, hypermethylation of multiple gene promoters (≥ 3) was encountered more frequently in females than in males (86 % versus 57 %, p = 0.04), whereas EBV-positive cases were more common among males than females (55 % versus 30 %, p = 0.02).

Conclusions

Our results indicate that epigenetic changes frequently occur in both EBV-positive and EBV-negative HL. The rates of these changes were found to vary according to clinico-pathological parameters. These observations probably reflect the multitude of factors involved in HL development and the complexity of their interactions with genetic and/or hormonal factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. H. Kanzler, R. Kuppers, M.L. Hansmann, K. Rajewsky, Hodgkin and reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495–1505 (1996)

  2. T. Marafioti, M. Hummel, H.D. Foss, H. Laumen, P. Korbjuhn, I. Anagnostopoulos, H. Lammert, G. Demel, J. Theil, T. Wirth, H. Stein, Hodgkin and reed–Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95, 1443–1450 (2000)

    CAS  PubMed  Google Scholar 

  3. R. Kuppers, identifying the precursors of Hodgkin and Reed-Sternberg cells in Hodgkin’s disease: role of the germinal center in B-cell lymphomagenesis. J. Acquir. Immune. Defic. Syndr. 21, 74–79 (1999)

  4. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman, (eds) World Health Organization Classification of Tumours.Pathologyand Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. (IARC Press, Lyon, 2001) pp 237–251

  5. P.A. McKinney, F.E. Alexander, T.J. Rickett, J. Williams, R.A. Cartwright, A specialist leukaemia/lymphoma registry in the UK. Part 1: incidence and geographical distribution of Hodgkin’s disease. Leukaemia research fund data collection study group. Br. J. Cancer 60, 942–947 (1989)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. S.L. Glasser, W.G. Swartz, Time trends in Hodgkin’s disease incidence. Role Diagn. Accuracy. Cancer. 66, 2196–2204 (1990)

    Google Scholar 

  7. S.L. Glaser, R.J. Lin, S.L. Stewart, R.F. Ambinder, R.F. Jarrett, P. Brousset, G. Pallesen, M.L. Gulley, G. Khan, J. O'Grady, M. Hummel, M.V. Preciado, H. Knecht, J.K. Chan, A. Claviez, Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int. J. Cancer 70, 375–382 (1997)

    Article  CAS  PubMed  Google Scholar 

  8. P.G. Murray, L.S. Young, M. Rowe, J. Crocker, Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J. Pathol. 166, 1–5 (1992)

    Article  CAS  PubMed  Google Scholar 

  9. P. Brousset, D. Schlaifer, F. Meggetto, E. Bachmann, S. Rothenberger, J. Pris, G. Delsol, H. Knecht, Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin’s disease. Blood 84, 2447–2451 (1994)

    CAS  PubMed  Google Scholar 

  10. E. Yiannakopoulou, Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents–implications for cancer treatment and chemoprevention. Cell. Oncol. 37, 167–178 (2014)

    Article  CAS  Google Scholar 

  11. J.S. de Groot, X. Pan, J. Meeldijk, E. van der Wall, P.J. van Diest, C.B. Moelans, Validation of DNA promoter hypermethylation biomarkers in breast cancer–a short report. Cell. Oncol. 37, 297–303 (2014)

    Article  Google Scholar 

  12. R. Singal, G.D. Ginder, DNA methylation. Blood 93, 4059–4070 (1999)

    CAS  PubMed  Google Scholar 

  13. S.B. Baylin, Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science 277, 1948–1949 (1997)

    Article  CAS  PubMed  Google Scholar 

  14. S.B. Baylin, J.G. Herman, DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174 (2000)

    Article  CAS  PubMed  Google Scholar 

  15. J.G. Herman, S.B. Baylin, Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042–2054 (2003)

    Article  CAS  PubMed  Google Scholar 

  16. M. Esteller, Relevance of DNA methylation in the management of cancer. Lancet Oncol. 4, 351–358 (2003)

    Article  CAS  PubMed  Google Scholar 

  17. A. Rawat G. AGopisetty, R. Thangarajan, E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells. Cell. Oncol. 37, 409–419 (2014)

  18. A. Yousuf, M.Y. Bhat, A.A. Pandith, D. Afroze, N.P. Khan, K. Alam, P. Shah, M.A. Shah, S. Mudassar, MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell. Oncol. 37, 245–252 (2014)

    Article  CAS  Google Scholar 

  19. F.A. Duijkers, R.X. de Menezes, I.J. Goossens-Beumer, D.J. Stumpel, P. Admiraal, R. Pieters, J.P. Meijerink, M.M. van Noesel, Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines. Cell. Oncol. 36, 351–362 (2013)

    Article  CAS  Google Scholar 

  20. O. Ammerpohl, A. Haake, S. Pellissery, M. Giefing, J. Richter, B. Balint, M. Kulis, J. Le, M. Bibikova, H.G. Drexler, M. Seifert, R. Shaknovic, B. Korn, R. Küppers, J.I. Martín-Subero, R, array based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes. Leukemia 26, 185–188 (2012)

    Article  CAS  PubMed  Google Scholar 

  21. A. Ushmorov, O. Ritz, M. Hummel, F. Leithäuser, P. Möller, H. Stein, T. Wirth, Epigenetic silencing of the immunoglobulin heavy chain gene in classical Hodgkin lymphoma -derived cell lines contributes to the loss ofimmunoglobulin expression. Blood 104, 3326–3334 (2004)

    Article  CAS  PubMed  Google Scholar 

  22. A. Ushmorov, F. Leithäuser, O. Sakk, Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 107, 2493–2500 (2006)

    Article  CAS  PubMed  Google Scholar 

  23. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, S.B. Baylin, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93, 9821–9826 (1996)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. K. Amara, M. Trimeche, S. Ziadi, Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes. Int. J. Cancer 121, 2693–2702 (2007)

    Article  CAS  PubMed  Google Scholar 

  25. R. Singal, L. Fredinand, I.M. Reis, J.J. Schlesselman, Methylation of multiple gene in prostate cancer and the relation with clinicopathological features and disease. Oncol. Rep. 12, 631–637 (2004)

    CAS  PubMed  Google Scholar 

  26. D. Astuti, A. Agathanggelou, S. Honorio, et al., RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastomatumours. Oncogene 20, 7573–7577 (2001)

    Article  CAS  PubMed  Google Scholar 

  27. M. Esteller, S. Tortola, M. Toyota, et al., Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res. 60, 129–133 (2000)

    CAS  PubMed  Google Scholar 

  28. R.A. Katzenellenbogen, S.B. Baylin, J.G. Herman, Hypermethylation of the DAP-kinase CpG island is a common alternation in B-cell malignancies. Blood 93, 4347–4353 (1999)

    CAS  PubMed  Google Scholar 

  29. M. Esteller, P.G. Corn, J.M. Urena, E. Gabrielson, S.B. Baylin, J.G. Herman, Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 58, 4515–4518 (1998)

    CAS  PubMed  Google Scholar 

  30. T. Oka, M. Ouchida, M. Koyama, et al., Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res. 62, 6390–6394 (2002)

    CAS  PubMed  Google Scholar 

  31. P.G. Corn, R.H. Heath, F. Fogt, A.A. Forastiere, J.G. Herman, T. Wu, Frequent hypermethylationof the 50 CpG island of E-cadherin in esophageal adenocarcinomas. Clin. Cancer Res. 7, 2765–2769 (2001)

    CAS  PubMed  Google Scholar 

  32. M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, J.G. Herman, Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59, 793–797 (1999)

    CAS  PubMed  Google Scholar 

  33. M.R. Gopal, B.J. Thomson, J. Fox, R.S. Tedder, R.W. Honess, Detection by pcr of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and hiv-seropositives. Lancet 335, 1598–1599 (1990)

    Article  CAS  PubMed  Google Scholar 

  34. M.G. Goll, T.H. Bestor, Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481–514 (2005)

    Article  CAS  PubMed  Google Scholar 

  35. M. Esteller, Epigenetics in cancer. N. Engl. J. Med. 358, 1148–1159 (2008)

    Article  CAS  PubMed  Google Scholar 

  36. R.F. Jarrett, J. MacKenzie, Epstein-Barr Virus and other candidate viruses in the pathogenesis of Hodgkin’s disease. Semin. Hematol. 36, 260–269 (1999)

    CAS  PubMed  Google Scholar 

  37. A.A. Armstrong, F.E. Alexander, R. Cartwright, et al., Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 12, 1272–1276 (1998)

    Article  CAS  PubMed  Google Scholar 

  38. K.R. Kim, T. Yoshizaki, H. Miyamori, et al., Transformation of madin-darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19, 1764–1771 (2000)

    Article  CAS  PubMed  Google Scholar 

  39. W.E. Miller, G. Mosialos, E. Kieff, N. Raab-Traub, Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappa B activation. J. Virol. 71, 586–594 (1997)

    PubMed Central  CAS  PubMed  Google Scholar 

  40. C.L. Tsai, H.P. Li, Y.J. Lu, et al., Activation of DNA methyltransferase1 by EBV LMP1 involves c-Jun NH(2)-terminal kinase signaling. Cancer Res. 66, 11668–11676 (2006)

    Article  CAS  PubMed  Google Scholar 

  41. F. Ksiaa, S. Ziadi, K. Amara, S. Korbi, M. Trimeche, Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma. Clin. Chim. Acta 404, 128–133 (2009)

    Article  CAS  PubMed  Google Scholar 

  42. M. Saito, J. Nishikawa, T. Okada, et al., Role of DNA methylation in the development of Epstein–Barr virus-associated gastric carcinoma. J. Med. Virol. 85, 121–127 (2013)

    Article  CAS  PubMed  Google Scholar 

  43. M.J. García, B. Martínez-Delgado, A. Cebrian, A. Martínez, J. Benítez, C. Rivas, Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-positive non-Hodgkin's lymphomas. Am J Pathol. 161, 1007–1013 (2002)

    Article  PubMed Central  PubMed  Google Scholar 

  44. K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, S. Korbi, Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. Ann. Oncol. 19, 1774–&è86 (2008)

  45. S. Challouf, S. Ziadi, R. Zaghdoudi, F. Ksiaa, R. Ben Gacem, M. Trimeche, Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients. Clin. Chim. Acta 413, 795–802 (2012)

    Article  CAS  PubMed  Google Scholar 

  46. P.G. Murray, G.H. Qiu, L. Fu, et al., Frequentepigeneticinactivationof the RASSF1Atumor suppressor gene inHodgkin's lymphoma. Oncogene 23, 1326–1331 (2004)

    Article  CAS  PubMed  Google Scholar 

  47. C. Wu, M. Sun, L. Liu, G.W. Zhou, The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 13, 1–12 (2003)

  48. S. Takeuchi, M. Matsushita, M. Zimmermann, et al., Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia. Leuk. Res. 35, 1345–1349 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. R.F. Jarrett, Viruses and Hodgkin's lymphoma. Ann. Oncol. 1, 23–29 (2002)

    Article  Google Scholar 

  50. A.A. Armstrong, L. Shield, A. Gallagher, R.F. Jarrett, Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease. Br. J. Cancer 77, 1045–1047 (1998)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. P. Brousset, V. de Araujo, R.D. Gascoyne, Immunohistochemical investigation of SV40largeTantigen in Hodgkin and non-Hodgkin's lymphoma. Int. J. Cancer 112, 533–535 (2004)

    Article  CAS  PubMed  Google Scholar 

  52. J. Hernández-Losa, C.G. Fedele, F. Pozo, A. Tenorio, V. Fernández, J. Castellví, C. Parada, S.A. Ramón y Cajal, Lack of association of polyomavirus and herpesvirus types 6 and 7in human lymphomas. Cancer. 103, 293–298 (2005)

    Article  PubMed  Google Scholar 

  53. A. Gallagher, J. Perry, L. Shield, J. Freeland, J. MacKenzie, R.F. Jarrett, Viruses and Hodgkin’s disease: no evidence of novel herpesviruses in non-EBV-associated lesions. Int. J. Cancer 101, 259–264 (2002)

    Article  CAS  PubMed  Google Scholar 

  54. O. Cohen, A. Kimchi, DAP-kinase:from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ. 8, 6–15 (2001)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the ‘Ministère de l’Enseignement Supérieur, de la Recherche Scientifique et de la Technologie’ and the ‘Ministère de la Sante’ of Tunisia.

The authors thank Intissar Klibi-Toumi, Samir Jaafar, and Houda Sghaier for their technical assistance.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, CHU Farhat-Hached, Sousse, Tunisia

    Myriam Ben Dhiab, Sonia Ziadi, Sarra Mestiri, Riadh Ben Gacem, Feryel Ksiaa & Mounir Trimeche

Authors
  1. Myriam Ben Dhiab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonia Ziadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarra Mestiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Riadh Ben Gacem
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Feryel Ksiaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mounir Trimeche
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mounir Trimeche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dhiab, M.B., Ziadi, S., Mestiri, S. et al. DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas. Cell Oncol. 38, 453–462 (2015). https://doi.org/10.1007/s13402-015-0242-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-015-0242-8

Keywords

Search

Navigation